2.10. siRNA reverse transfection

RM Rebecca L. Mather
AP Abhijit Parolia
SC Sandra E. Carson
EV Erik Venalainen
DR David Roig‐Carles
MJ Mustapha Jaber
SC Shih‐Chun Chu
IA Ilaria Alborelli
RW Rebecca Wu
DL Dong Lin
NN Noushin Nabavi
EJ Elena Jachetti
MC Mario P. Colombo
HX Hui Xue
PP Perla Pucci
XC Xinpei Ci
CH Cheryl Hawkes
YL Yinglei Li
HP Hardev Pandha
IU Igor Ulitsky
CM Crystal Marconett
LQ Luca Quagliata
WJ Wei Jiang
IR Ignacio Romero
YW Yuzhuo Wang
FC Francesco Crea
request Request a Protocol
ask Ask a question
Favorite

Knockdown studies were performed using the reverse transfection method. Cells were seeded in a six‐well or 96‐well plate with lipid:siRNA mixture prepared using Lipofectamine 2000 (Invitrogen, Loughborough, UK) as per manufacturer's protocol. Final siRNA concentrations were 10 nmol. All dicer substrate short interfering RNAs against LINC00261 were purchased from Integrated DNA Technologies (Leuven, Belgium) [hs.Ri.LINC00261.13.1 (siRNA 1), hs.Ri.LINC00261.13.2 (siRNA 2), and hs.Ri.LINC00261.13.3 (siRNA 3)]. Control siRNAs were also purchased from IDT (negative control DS NC1 and positive control HPRT‐S1 DS). For murine cells, silencer select siRNAs against 9030622O22‐Rik were purchased (siRNA 1 = n404958, siRNA 2 = n440961, and siRNA 3 = n518634, as well as negative control; Thermo) and transfected with 25 nm in the same manner previously described. RNA was isolated using RNeasy Plus Mini Kit (Qiagen).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A